Search
Xontogeny's Chris Garabedian gives a year-end review and looks ahead to biotech's 2024
Chris Garabedian's thoughts on the IPO market, products vs platforms, and more discipline and prioritization in biotech.
Dec 27, 2023
top of page
Search
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
.png){kind=logo}
Sponsor Spotlight
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.
bottom of page